EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines

Alina Tscherne iD, Rebecca Jane Cox iD, Florian Krammer, Anders Bonnevie iD

Influenza and Other Respiratory Viruses · 2026

DOI: 10.1111/irv.70258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2026. Verfasst von Alina Tscherne und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Orthomyxoviridae Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This report summarizes the discussions and conclusions from the fourth “Correlates of Protection for Next Generation Influenza Vaccines” meeting, which took place in Vienna, Austria, from October 15, 2025, to October 17, 2025.

Conclusion

Discussions on influenza virus correlates of protection built on prior meetings, with particular emphasis on challenges introduced by novel vaccine platforms and evolving regulatory expectations. Although established immune markers such as hemagglutination inhibiting (HI) antibodies remain central to influenza vaccine evaluation, this year's discussions highlighted the continued uncertainty and challenges around their generalizability across platforms, populations, and age groups. Regulatory perspectives emphasized the need for strong biological and clinical justification linking immune markers to protection. Overall, the meeting highlighted the importance of continued collaboration among academia, industry, and regulatory agencies to advance the identification and validation of correlates of protection, in alignment with priorities outlined in the 2025 influenza research and development road map for influenza vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanOrthomyxoviridae InfectionsHumansAnimalsAntibodies, ViralVaccine DevelopmentAustria

Stichwörter der Autor:innen

animal modelcellular immunitycorrelates of protectionepidemiological modellinginfluenzainfluenza vaccinemRNA vaccinemucosal immunityvaccine platform

Substanzen

Influenza VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria.
  • Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Alina Tscherne, Rebecca Jane Cox, Anders Bonnevie

Zitieren

APA

Tscherne, A., Cox, R. J., Krammer, F., & Bonnevie, A. (2026). Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70258

Vancouver

Tscherne A, Cox RJ, Krammer F, Bonnevie A. Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines. Influenza and Other Respiratory Viruses. 2026. doi:10.1111/irv.70258

BibTeX
@article{Tscherne2026,
  author = {Tscherne, Alina and Cox, Rebecca Jane and Krammer, Florian and Bonnevie, Anders},
  title = {Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2026},
  doi = {10.1111/irv.70258}
}
Kostenlos starten →